No Detail Found!

Correlation of adiposity markers with metabolic dysfunction associated fatty liver disease in Type II Diabetes Mellitus

Author(s)
Rabiya Ali Departments of Physiology, Karachi Institute of Medical Sciences, Sindh, Pakistan.
Saif Ullah Shaikh Bahria University Health Sciences, Karachi, Pakistan
Muhammad Sajid Abbas Jaffery Bahria University Medical and Dental College, Karachi, Pakistan.
Shireen Jawed Aziz Fatima Medical and Dental College, Faisalabad, Pakistan.
Mehir un-Nisa Iqbal University of Karachi, Pakistan
Abstract
Objective: To investigate the relationship between body mass index (BMI), waist circumference (WC), hip circumference (HC), waist-to-hip ratio (WHR), total body fat, visceral fat (VF), and Non-alcoholic fatty liver disease (NAFLD) in individuals with Type II Diabetes Mellitus (T2DM). Methodology: This cross-sectional study included 153 T2DM patients aged 40-65yrs recruited from the Tertiary Hospitals, Karachi. Data pertaining to anthropometric measurements (BMI, WC, HC, WHR, and VF) and glycosylated hemoglobin (HgA1c) were recorded along with ultrasound scan findings of NAFLD. Results: In this study, 129 patients had T2DM with NAFLD. Among them, 66 were obese, 41 were overweight, and 22 patients had normal BMI. The remaining 24 were non-diabetic-NAFLD patients, out of which 18 were obese and 6 were overweight. The mean HbA1c, WC, WHR, and VF were 9.0g/dl, 88.94cm, 1.051cm, and 12.81cm, respectively. Among various anthropometric indicators, WHR (p=0.040) and VF (p=0.042) showed a significant association with NAFLD in T2DM, while BMI (p=0.91), HbA1c (p=0.857), and WC (p=0.268) did not show a significant association. Conclusion: The indicators of visceral adiposity like WHR and VF were more significantly associated with NAFLD in T2DM than WC and BMI.
Publication Details
Page(s) 64-67
DOI DOI not available
Published Journal: Rawal Medical Journal, Volume: 50, Issue: 1, Year: 2025

Request the full text from PASTIC

Keywords
BMI, waist circumference, hip circumference, Nonalcoholic fatty liver disease, Visceral fat, Metabolic dysfunction, Type II diabetes patients, Adiposity markers, Waist-hip ratio.
References
Drożdż K,Nabrdalik K,Hajzler W,Kwiendacz H,Gumprecht J,Lip GY .2021 .Metabolic-associated fatty liver disease (MAFLD), diabetes, and cardiovascular disease: Associations with fructose metabolism and gut microbiota. Nutrients, 14 : 103-7.
Targher G,Byrne CD,Tilg H. NAFLD .2020 .and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms, and pharmacological implications. Gut, 69 : 1691-705.
Cai J,Lin C,Lai S,Liu Y,Liang M,Qin Y .2021 .Waist-toheight ratio, an optimal anthropometric indicator for metabolic dysfunction associated fatty liver disease in the Western Chinese male population. Lipids Health Dis, 20 : 1-12.
Fukuda T,Hamaguchi M,Kojima T,Hashimoto Y,Ohbora A,Kato T .2016 .The impact of non‐alcoholic fatty liver disease on incident type 2 diabetes mellitus in non‐overweight individuals. Liver Intl, 36 : 275-83.
Malek M,Khamseh ME,Chehrehgosha H,Nobarani S .2021 .Triglyceride glucose-waist to height ratio: a novel and effective marker for identifying hepatic steatosis in individuals with type 2 diabetes mellitus. Endocrine, 74 : 538-45.
Ballestri S,Zona S,Targher G,Romagnoli D,Baldelli E,Nascimbeni F .2016 .Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta‐analysis. J Gastroentrol Hepatol, 31 : 936-44.
.1998 .-guidelinesidentification-evaluation-and-treatment-overweight-andobesity-adults. National Institutes of Health, National Heart, : .
Obesity .2000 .: preventing and managing the global epidemic. WHO Technical Rep Series, 894 : 1-253.
Azarbad A,Aghnia T,Gharibzadeh A,Rafati S,Hashemi SM,Zarei H .2022 .Cut-off points for anthropometric indices to screen for hypertension among Iranian adults of the BandareKong cohort: a cross-sectional study. BMC Public Health, 22 : 2064-7.
Succurro E,Marini MA,Fiorentino TV,Perticone M,Sciacqua A,Andreozzi F .2022 .Sex-specific differences in prevalence of nonalcoholic fatty liver disease in subjects with prediabetes and type 2 diabetes. Diabetes Res Clin Pract, 190 : 110027.
Musso G,Gambino R,Cassader M. .2009 .Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). Prog Lipid Res, 48 : 1-26.
Bhatt HB,Smith RJ .2015 .Fatty liver disease in diabetes mellitus. Hepatobiliary Surg Nutr, 4 : 101-5.
Oz I,Bilici M,Serifoglu I,Arpaci DK,Buyukuysal M,Bayraktaroglu T. .2017 .Association of pancreas volume and insulin resistance with abdominal fat distribution in type-2 diabetes as evaluated by computed tomography. Acta Endocrinol (Buchar), 13 : 168-71.
Indulekha K,Anjana RM,Surendar J,Mohan V .2011 .Association of visceral and subcutaneous fat with glucose intolerance, insulin resistance, adipocytokines and inflammatory markers in Asian Indians (CURES-113. Clin Biochem, 44 : 281-7.
Ge X,Zheng L,Wang M,Du Y,Jiang J. Y .2020 .a population-based observational study. BMJ Open, 10 : e036663.
Zar A,Ali SS A .2022 .Visceral Adiposity Index: A Simple Tool for Assessing Risk of Type 2 Diabetes Mellitus. J Ayub Med Coll Abbottabad, 34 : 345-50.
Dharmalingam M,Yamasandhi PG .2018 .Nonalcoholic fatty liver disease and type 2 diabetes mellitus. Indian J Endocrinol Metab, 22 : 421-5.
Radu F,Potcovaru C-G,Salmen T,Filip PV,Pop C,Fierbințeanu-Braticievici C. C .2023 .The Link between NAFLD and Metabolic Syndrome. Diagnostics, 13 : 614-8.
Vilalta A,Gutiérrez JA,Chaves S,Hernández M,Urbina S,Hompesch M. .2022 .Adipose tissue measurement in clinical research for obesity, type 2 diabetes,. NAFLD/NASH. Endocrinol Diabetes Metab J, 5 : e00335.
0

Citations

0

Downloads

671

Views